Astellas Pharma | 4503 - Operating Expenses

Stock Price
2,607.50
Daily Change
20.50 0.79%
Monthly
10.02%
Yearly
100.35%
Q2 Forecast
2,473.95

Astellas Pharma reported JPY436.66B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Astellas Pharma JPY 436.66B 16.75B Dec/2025
Chugai Pharma JPY 177.3B 604M Dec/2025
Daiichi Sankyo JPY 468.57B 15.34B Dec/2025
Eisai JPY 199.9B 16.22B Dec/2025
Kyowa Hakko Kirin JPY 109.02B 16.08B Dec/2025
M3 JPY 67.49B 1.51B Dec/2025
Otsuka Holdings JPY 582.9B 113.74B Dec/2025
Shionogi JPY 73.75B 240M Dec/2025
Sumitomo Dainippon JPY 43.46B 43.51B Sep/2025
Takeda JPY 1.02T 400.98B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025